share_log
Benzinga ·  08/28 17:15

BioCardia Says FDA Has Cleared Company To Market Its Morph DNA Steerable Introducer Product Family, Subject To The General Controls Provisions Of The Federal Food, Drug And Cosmetic Act - Filing

Biocardia宣布美国FDA已经批准该公司按照联邦食品、药物和化妆品法规的通用控制规定开始销售其Morph DNA可操纵导管产品系列

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发